Evaluation of the efficacy of Xinmupei combined with ergometrine maleate in the treatment of postpartum hemorrhage in women undergoing vaginal delivery
欣母沛联合马来酸麦角新碱治疗经阴道分娩产后出血产妇的效果评价

摘要

目的 分析探讨欣母沛联合马来酸麦角新碱治疗经阴道分娩产后出血产妇的效果评价。方法 选择我院2023年9月-2024年9月所接收的10例经阴道分娩产后出血产妇为研究对象，随机数字法分为观察组（欣母沛联合马来酸麦角新碱治疗）与对照组（马来酸麦角新碱治疗），比较两组产后出血量、凝血指标以及预后不良反应发生情况。结果 观察组产后2h与24h出血量（251.41±23.62ml，382.45±25.65ml）均低于对照组，治疗后观察组凝血酶原时间与活化部分凝血活酶时间以及活化部分凝血活酶时间均优于对照组，不良反应风险率低于对照组（P<0.05）。结论 欣母沛联合马来酸麦角新碱治疗经阴道分娩产后出血产妇的效果明显，值得广泛推广与应用。

Abstract

Objective To analyze and explore the efficacy evaluation of Xinmupei combined with ergometrine maleate in the treatment of postpartum hemorrhage in women undergoing vaginal delivery.
Methods Ten postpartum hemorrhage women who underwent vaginal delivery in our hospital from September 2023 to September 2024 were selected as the research subjects. They were randomly divided into an observation group (treated with Xinmupei combined with ergometrine maleate) and a control group (treated with ergometrine maleate). The postpartum hemorrhage volume, coagulation indicators, and incidence of adverse reactions in the two groups were compared.
Results The bleeding volume at 2 hours and 24 hours postpartum in the observation group (251.41 ± 23.62ml,382.45±25.65ml) was lower than that in the control group. After treatment, the prothrombin time, activated partial thromboplastin time, and activated partial thromboplastin time in the observation group were better than those in the control group, and the risk of adverse reactions was lower than that in the control group (P<0.05).
Conclusion   The combination of Xinmupei and ergometrine maleate is effective in treating postpartum hemorrhage in women undergoing vaginal delivery, and is worthy of widespread promotion and application.